Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-22

Clinical Trial Update: Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating the efficacy of a telmisartan/amlodipine combination for 24-hour blood pressure control in hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan/Amlodipine (telmisartan and amlodipine)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 4 | Status: UNKNOWN